Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...

The 2025 American Society of Hematology (ASH) meeting in December presented a clear message: scientific innovation and ...

Launched KOMZIFTI™ (ziftomenib), first and only once-daily, oral menin inhibitor approved for adults with R/R NPM1-mutated ...

Cell division is an essential process for all life on Earth, yet the exact mechanisms by which cells divide during early ...

Scientists have uncovered a new explanation for how swimming bacteria change direction, providing fresh insight into one of ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

Peptide science has emerged as a pivotal area in the development of novel therapeutic agents for oral diseases. Oral diseases ...

Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...